BCRX Financial Facts

Total revenues: 7.76M
Royalties: 3.5M
See Full Income Statement

Cash and cash equivalents: 35.39M
Deferred collaboration expense: 98K
See Full Balance Sheet

BioCryst Pharmaceuticals, Inc. (BCRX) Earnings

  |   Expand Research on BCRX
Next EPS Date N/A EPS Growth Rate -25.0% *Last Qtr.
Average EPS % Beat Rate -10.0% Revenue Growth Rate -30.0% *Last Qtr.
Average % Move 1-Wk after EPS -3.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/4/19 Q418 -$0.25-$0.25 $0.00$2.73M$2.82M N/A Details
11/6/18 Q318 -$0.28-$0.25 -$0.03$1.5M$3.77M N/A Details
2/27/18 Q417 -$0.20-$0.15 -$0.05$3.9M$4.93M = Details
11/7/17 Q317 -$0.18-$0.19 +$0.01$8.8M$4.62M = Details
8/7/17 Q217 -$0.21-$0.19 -$0.02$3.1M$5.79M = Details
5/4/17 Q117 -$0.19-$0.19 $0.00$9.4M$5.26M = Details
2/27/17 Q416 -$0.06-$0.23 +$0.17$9M$4.13M = Details
11/7/16 Q316 -$0.16-$0.24 +$0.08$7.8M$5.94M N/A Details